Processa Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity, Disclosure: Schedule of Stock Option Activity (Tables)

9 Months Ended

Sep. 30, 2016

	Number of Options	Weighted Average Exercise Price	Weighted Average Remaining Life (Years)
Balance, December 31, 2015	591,167	$ 1.78	3.75
Granted	--	$ --	--
Exercised	--	$ --	--
Cancelled	(321,667)	$ 1.69	--
Balance, September 30, 2016	269,500	$ 1.88	2.29
Exercisable, September 30, 2016	269,500	$ 1.88	2.29